Thermo Fisher Scientific Expands Steriles Manufacturing and Research Capabilities in Asia-Pacific Region
When a client tells us that our internal processes are getting in the way of meeting their needs, we take it to heart. That’s the position Whitney faced when her client felt that her facility, originally designed for GMP biologic drug substance commercial manufacturing, was too rigid for the fast-paced, rapidly-changing world of clinical manufacturing. So, she pulled together a cross-functional team that included Quality, Tech Transfer, and Biological Sciences, to take a new look at their commercial quality processes to determine how they could appropriately adapt them to meet the unique needs of their clients in development phases. And the change worked. Now her facility can deliver the robust and reliable commercial process it has always been known for, as well as the more flexible, faster-turn execution needed for clinical. Best of all, her clients can get to clinical trial faster and expedite delivering medicines to the patients who need them most.